BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16052541)

  • 1. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Teng YK; Verburg RJ; Sont JK; van den Hout WB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2005 Aug; 52(8):2272-6. PubMed ID: 16052541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
    Verburg RJ; Sont JK; Vliet Vlieland TP; Landewé RB; Boers M; Kievit J; van Laar JM
    J Rheumatol; 2001 Apr; 28(4):719-27. PubMed ID: 11327241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
    Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.
    Kosinski M; Kujawski SC; Martin R; Wanke LA; Buatti MC; Ware JE; Perfetto EM
    Am J Manag Care; 2002 Mar; 8(3):231-40. PubMed ID: 11915973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.
    Salaffi F; Stancati A; Carotti M
    Clin Rheumatol; 2002 Nov; 21(6):478-87. PubMed ID: 12447631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health status and perception of pain: a comparative study between female patients with hand osteoarthritis and rheumatoid arthritis.
    Slatkowsky-Christensen B; Mowinckel P; Kvien TK
    Scand J Rheumatol; 2009; 38(5):342-8. PubMed ID: 19585382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.
    Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE
    Arthritis Rheum; 2000 Jul; 43(7):1478-87. PubMed ID: 10902749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
    Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J
    Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population.
    Uhlig T; Loge JH; Kristiansen IS; Kvien TK
    J Rheumatol; 2007 Jun; 34(6):1241-7. PubMed ID: 17516624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.
    Heiberg MS; Nordvåg BY; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
    Arthritis Rheum; 2005 Aug; 52(8):2506-12. PubMed ID: 16052584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L; Braakman-Jansen LM; Taal E; Kievit W; Visser H; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
    Boonen A; Patel V; Traina S; Chiou CF; Maetzel A; Tsuji W
    J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Kvamme MK; Kristiansen IS; Lie E; Kvien TK
    J Rheumatol; 2010 Jan; 37(1):26-31. PubMed ID: 19955045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.